EP2904009
Efnasambönd til að meðhöndla bælingu endurmýlingar í sjúkdómum sem tengjast tjáningu HERV-W hjúpprótínsins
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
1.10.2013EP published:
21.11.2018EP application number:
13770926.7
EP translation filed:
7.2.2019Grant published:
15.3.2019EPO information:
European Patent Register
Max expiry date:
30.9.2033Expiry date:
30.9.2024
Title:
COMPOUNDS FOR TREATING THE REMYELINATION BLOCKADE IN DISEASES ASSOCIATED WITH THE EXPRESSION OF HERV-W ENVELOPE PROTEIN
Timeline
Today
1.10.2013EP application
21.11.2018EP Publication
7.2.2019Translation submitted
15.3.2019Registration published
30.9.2024Expires
Owner
Name:
Geneuro SAAddress:
3 Chemin du Pré-Fleuri, 1228, Plan-Les-Ouates, CH
Inventor
Name:
PERRON, HervéAddress:
Saint Genis les Ollières, FR
Name:
FIROUZI, RezaAddress:
deceased, FR
Name:
KÜRY, PatrickAddress:
Düsseldorf, DE
Name:
FAUCARD, RaphaëlAddress:
Mont-Saxonnex, FR
Name:
MADEIRA, AlexandraAddress:
Mont-Saxonnex, FR
Name:
JOANOU, JulieAddress:
Rive de Gier, FR
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201261708779 PDate:
2.10.2012Country:
US
Number:
201261746792 PDate:
28.12.2012Country:
US
Classification
Categories:
C07K 16/10, A61K 39/42, A61K 31/155, A61K 31/194, A61K 31/221, A61K 31/223, A61K 31/225, A61K 45/06, A61P 25/28
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 13.9.2019
Expires: 30.9.2020
Payer: Acumass
Number: 8
Paid: 15.9.2020
Expires: 30.9.2021
Payer: Acumass
Number: 9
Paid: 17.9.2021
Expires: 30.9.2022
Payer: Acumass
Number: 10
Paid: 15.9.2022
Expires: 30.9.2023
Payer: Acumass
Number: 11
Paid: 20.9.2023
Expires: 30.9.2024
Payer: Acumass